Home Capital Group Inc.

HCG.TO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCG.TO stands at 1.7B. In comparison, EQB.TO has a market cap of 3.8B. Regarding current trading prices, HCG.TO is priced at CA$44.27, while EQB.TO trades at CA$98.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCG.TO currently has a P/E ratio of 9.88, whereas EQB.TO's P/E ratio is 10.12. In terms of profitability, HCG.TO's ROE is +0.10%, compared to EQB.TO's ROE of +0.17%. Regarding short-term risk, HCG.TO is less volatile compared to EQB.TO. This indicates potentially lower risk in terms of short-term price fluctuations for HCG.TO.

HCG.TO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCG.TO stands at 1.7B. In comparison, FN.TO has a market cap of 2.5B. Regarding current trading prices, HCG.TO is priced at CA$44.27, while FN.TO trades at CA$41.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCG.TO currently has a P/E ratio of 9.88, whereas FN.TO's P/E ratio is 14.36. In terms of profitability, HCG.TO's ROE is +0.10%, compared to FN.TO's ROE of +0.24%. Regarding short-term risk, HCG.TO is less volatile compared to FN.TO. This indicates potentially lower risk in terms of short-term price fluctuations for HCG.TO.

HCG.TO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCG.TO stands at 1.7B. In comparison, MKP.TO has a market cap of 751.7M. Regarding current trading prices, HCG.TO is priced at CA$44.27, while MKP.TO trades at CA$19.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCG.TO currently has a P/E ratio of 9.88, whereas MKP.TO's P/E ratio is 10.40. In terms of profitability, HCG.TO's ROE is +0.10%, compared to MKP.TO's ROE of +0.12%. Regarding short-term risk, HCG.TO is less volatile compared to MKP.TO. This indicates potentially lower risk in terms of short-term price fluctuations for HCG.TO.

HCG.TO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCG.TO stands at 1.7B. In comparison, DLCG.TO has a market cap of 686.8M. Regarding current trading prices, HCG.TO is priced at CA$44.27, while DLCG.TO trades at CA$8.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCG.TO currently has a P/E ratio of 9.88, whereas DLCG.TO's P/E ratio is -3.44. In terms of profitability, HCG.TO's ROE is +0.10%, compared to DLCG.TO's ROE of -1.50%. Regarding short-term risk, HCG.TO is less volatile compared to DLCG.TO. This indicates potentially lower risk in terms of short-term price fluctuations for HCG.TO.

HCG.TO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCG.TO stands at 1.7B. In comparison, TF.TO has a market cap of 634.7M. Regarding current trading prices, HCG.TO is priced at CA$44.27, while TF.TO trades at CA$7.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCG.TO currently has a P/E ratio of 9.88, whereas TF.TO's P/E ratio is 13.46. In terms of profitability, HCG.TO's ROE is +0.10%, compared to TF.TO's ROE of +0.07%. Regarding short-term risk, HCG.TO is less volatile compared to TF.TO. This indicates potentially lower risk in terms of short-term price fluctuations for HCG.TO.

HCG.TO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCG.TO stands at 1.7B. In comparison, AI.TO has a market cap of 548.9M. Regarding current trading prices, HCG.TO is priced at CA$44.27, while AI.TO trades at CA$11.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCG.TO currently has a P/E ratio of 9.88, whereas AI.TO's P/E ratio is 11.21. In terms of profitability, HCG.TO's ROE is +0.10%, compared to AI.TO's ROE of +0.10%. Regarding short-term risk, HCG.TO is less volatile compared to AI.TO. This indicates potentially lower risk in terms of short-term price fluctuations for HCG.TO.

HCG.TO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCG.TO stands at 1.7B. In comparison, FC.TO has a market cap of 448.9M. Regarding current trading prices, HCG.TO is priced at CA$44.27, while FC.TO trades at CA$12.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCG.TO currently has a P/E ratio of 9.88, whereas FC.TO's P/E ratio is 12.10. In terms of profitability, HCG.TO's ROE is +0.10%, compared to FC.TO's ROE of +0.09%. Regarding short-term risk, HCG.TO is less volatile compared to FC.TO. This indicates potentially lower risk in terms of short-term price fluctuations for HCG.TO.

HCG.TO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCG.TO stands at 1.7B. In comparison, STX.CN has a market cap of 2.6M. Regarding current trading prices, HCG.TO is priced at CA$44.27, while STX.CN trades at CA$0.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCG.TO currently has a P/E ratio of 9.88, whereas STX.CN's P/E ratio is -0.29. In terms of profitability, HCG.TO's ROE is +0.10%, compared to STX.CN's ROE of -1.67%. Regarding short-term risk, HCG.TO is more volatile compared to STX.CN. This indicates potentially higher risk in terms of short-term price fluctuations for HCG.TO.